Lornox 8 mg 30 tablets
Composition:
Lornoxicam 8 mg.
Excipients: lactose monohydrate, povidone K25, starch, Avicel, Aerosil.
Product Description
Lornoxicam is a non‑steroidal anti‑inflammatory drug (NSAID) from the oxicam class.
It has pronounced anti‑inflammatory, analgesic, antipyretic, and anti‑platelet effects.
The mechanism of action is associated with suppression of prostaglandin synthesis through inhibition of COX‑1 and COX‑2, leading to reduced inflammation and pain.
It suppresses both the exudative and proliferative phases of the inflammatory process.
Indications for Use
Rheumatoid arthritis.
Osteoarthritis.
Ankylosing spondylitis.
Joint syndrome in acute gout.
Bursitis, tendovaginitis.
Moderate to severe pain (arthralgia, myalgia, neuralgia, lumbago, sciatica, migraine, toothache, headache, dysmenorrhea, pain from trauma and burns).
Fever associated with colds and infectious diseases.
Method of Administration and Dosage
Orally, 8 mg. If analgesic effect is insufficient, an additional 8 mg may be taken.
Maximum daily dose (oral): 16 mg.
Contraindications
Acute gastrointestinal bleeding.
Peptic ulcer of the stomach or duodenum in the acute phase.
Ulcerative colitis in the acute phase.
Bronchial asthma.
Severe chronic heart failure.
Hypovolemia.
Blood clotting disorders (hemophilia, hemorrhagic diathesis, thrombocytopenia).
Severe hepatic and/or renal failure.
Glucose‑6‑phosphate dehydrogenase deficiency.
Cerebral hemorrhage (including suspected).
Pregnancy and breastfeeding.
Children and adolescents under 18 years.
Hypersensitivity to lornoxicam, acetylsalicylic acid, or other NSAIDs.
Precautions
Use with caution in patients with a history of erosive‑ulcerative lesions or gastrointestinal bleeding, moderate renal impairment, post‑surgical conditions, elderly patients (over 65 years), and those weighing less than 50 kg.
Regular monitoring of renal function is required during treatment in patients with renal impairment.
Use only after careful assessment of benefit/risk in cases of heart failure, hypertension, liver or kidney dysfunction, fluid retention and edema, or after major surgery.
Lornoxicam reduces psychomotor reaction speed; caution is advised when driving or operating potentially hazardous machinery during treatment.
Adverse Reactions / Side Effects
Possible dyspeptic disorders, nausea, abdominal pain.
Rare: allergic reactions, skin rash, itching.
With prolonged use: risk of ulcer formation and gastrointestinal bleeding.
Pregnancy and Lactation
Contraindicated during pregnancy and breastfeeding.
Storage Conditions
Store at temperatures not exceeding 30°C, in a dry place.
Packaging
Cardboard box containing 3 blisters of 10 tablets and instructions.